In 2003, a case of osteonecrosis of the jaw related with medicine was documented for the
first time. In the past, osteonecrosis of the jaw was thought to be caused by intravenous and …

Objective To evaluate the 12-months incidence of MRONJ after tooth extractions and
possible related risk factors in patients with osteoporosis treated by means of oral …

Medication-related osteonecrosis of the jaw (MRONJ) is a well-known pathologic entity in
the field of oral and maxillofacial surgery. Whether evaluating patients initiating …

Aim: The aim of this study was to evaluate dentists on their knowledge on biphosphonates,
medication related osteonecrosis of the jaw (MRONJ), and on the treatment approaches …

Root amputation, extraction of a single tooth, bone loss or severe tooth mobility, and an
unclosed wound were significantly associated with increased risk of developing medication …

Oral and maxillofacial surgeons first recognized and reported cases of nonhealing exposed
bone in the maxillofacial region of patients treated with intravenous (IV) bisphosphonates in …

Medication-related osteonecrosis of the jaw (MRONJ) is a rare, severe debilitating condition
from unknown causes. It is characterized by nonhealing exposed bone in a patient with a …

We read the study by Hasegawa et al. with great interest, which sought to determine the
associations between different risk factors, such as demographic features, primary wound …

Background: Medication-Related Osteonecrosis of the Jaw (MRONJ) can occur as an
adverse reaction to several antiresorptive medications such as bisphosphonate. It presents …

Background Medication-related osteonecrosis of the jaw (MRONJ) is a preventable
complication of antiresorptive treatment. It arises in 1–20% of patients with bone metastases …